SCHEMBL7207581

SCHEMBL7207581

O=S(=O)(c1ccccc1Sc1ccccc1)[C@@H]1CCC[C@H](S)C1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 5/20 0.68
MMP8 P22894 3/20 0.68
MMP1 P03956 2/20 0.51
ADAM17 P78536 3/20 0.39
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 2/20 0.35
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
NSD2 O96028 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409860 1.00 MMP13 (0.68) MMP13MMP8MMP1ADAM17NPSR1
SCHEMBL7409863 1.00 MMP13 (0.68) MMP13MMP8MMP1ADAM17NPSR1
SCHEMBL7409866 1.00 MMP13 (0.68) MMP13MMP8MMP1ADAM17NPSR1
SCHEMBL7212111 0.81 MMP13 (1.00) MMP13MMP8MMP1ADAM17MAPT
SCHEMBL5013613 0.65 CA2 (0.51) KDM4ENSD2MAPTMAPK1LMNA
SCHEMBL5683257 0.65 MAPT (0.46) KMT2AKDM4ENSD2MAPTMAPK1
SCHEMBL10789247 0.65 MAPT (0.46) NPSR1KMT2AKDM4ENSD2MAPT
SCHEMBL7212033 0.65 MMP13 (0.71) MMP13MMP8MMP1ADAM17MAPT
SCHEMBL10413097 0.65 SIRT1 (0.47) NPSR1KMT2AKDM4ENSD2MAPT
SCHEMBL9626218 0.64 HTR6 (0.50) NPSR1HTTKMT2AKDM4ENSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0939628-B1 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO CO (US) 2003-03-05 EP disclosed
US-6013649-A BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS MONSANTO COMPANY (US) 2000-01-11 US disclosed